Genetic
Epigenetic signatures
Epigenetic signatures is a genetic therapy with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
GENETIC
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(1)
Other(3)
Detailed Status
unknown3
Completed1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Trials by Status
unknown375%
completed125%
Recent Activity
0 active trials
Showing 4 of 4
completed
Better Delineation of BCL11B Related Phenotype and Epigenetic Signature.
NCT04541927
unknown
Better Delineation of DDX3X Related Phenotype and Epigenetic Signature.
NCT04436588
unknown
Better Delineation of YY1 Related Phenotype and Epigenetic Signatures.
NCT04381715
unknown
Better Delineation of CDK13 Related Phenotype and Epigenetic Signature.
NCT04382573
Clinical Trials (4)
Showing 4 of 4 trials
NCT04541927
Better Delineation of BCL11B Related Phenotype and Epigenetic Signature.
NCT04436588
Better Delineation of DDX3X Related Phenotype and Epigenetic Signature.
NCT04381715
Better Delineation of YY1 Related Phenotype and Epigenetic Signatures.
NCT04382573
Better Delineation of CDK13 Related Phenotype and Epigenetic Signature.
All 4 trials loaded
Drug Details
- Intervention Type
- GENETIC
- Total Trials
- 4